Stock Earnings

Question 1

What are Shanghai Junshi Biosciences Co Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Shanghai Junshi Biosciences Co Ltd has a total asset of $10,782, Net loss of $-1,280

Question 2

What are the key financial ratios for SHJBF?

Accepted Answer

Shanghai Junshi Biosciences Co Ltd's Current ratio is 2.19, has a Net margin is -65.7, sales per share of $1.97.

Question 3

How is Shanghai Junshi Biosciences Co Ltd's revenue broken down by segment or geography?

Accepted Answer

Shanghai Junshi Biosciences Co Ltd largest revenue segment is Innovative Drugs, at a revenue of 1,948,317,315 in the most earnings release.For geography, China is the primary market for Shanghai Junshi Biosciences Co Ltd, at a revenue of 1,853,570,980.

Question 4

Is Shanghai Junshi Biosciences Co Ltd profitable?

Accepted Answer

no, according to the latest financial statements, Shanghai Junshi Biosciences Co Ltd has a net loss of $-1,280

Question 5

Does Shanghai Junshi Biosciences Co Ltd have any liabilities?

Accepted Answer

yes, Shanghai Junshi Biosciences Co Ltd has liability of 4,922

Question 6

How many outstanding shares for Shanghai Junshi Biosciences Co Ltd?

Accepted Answer

Shanghai Junshi Biosciences Co Ltd has a total outstanding shares of 985

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	2,482	1,948	1,502	1,453	4,024	1,594
Revenue Growth (YoY)	39%	30%	3%	-64%	152%	106%
Cost of Revenue	456	523	634	526	1,258	376
Gross Profit	2,025	1,424	868	927	2,766	1,218
Selling, General & Admin	1,541	1,347	1,337	1,178	1,272	1,068
Research & Development	1,383	1,189	1,813	2,269	1,988	1,733
Operating Expenses	3,028	2,705	3,347	3,646	3,360	2,895
Other Non Operating Income (Expenses)	-24	-17	-33	-11	-36	-15
Pretax Income	-1,065	-1,357	-2,491	-2,677	-595	-1,672
Income Tax Expense	0	22	43	-93	135	-3
Net Income	-949	-1,280	-2,283	-2,388	-720	-1,668
Net Income Growth	-47%	-44%	-4%	231.99%	-56.99%	123%
Shares Outstanding (Diluted)	1,013.28	985.68	984.23	918.48	890.01	822
Shares Change (YoY)	4%	0%	7%	3%	8%	6%
EPS (Diluted)	-0.93	-1.29	-2.32	-2.6	-0.81	-2.03
EPS Growth	-50%	-44%	-11%	221%	-60%	111%
Free Cash Flow	-1,243	-2,124	-2,837	-2,170	-1,506	-2,036
Free Cash Flow Per Share	-1.22	-2.15	-2.88	-2.36	-1.69	-2.47
Gross Margin	81.58%	73.1%	57.78%	63.79%	68.73%	76.41%
Operating Margin	-40.37%	-65.7%	-165.04%	-187.06%	-14.76%	-105.2%
Profit Margin	-38.23%	-65.7%	-151.99%	-164.34%	-17.89%	-104.64%
Free Cash Flow Margin	-50.08%	-109.03%	-188.88%	-149.34%	-37.42%	-127.72%
EBITDA	--	-1,056	-2,236	-2,487	-404	-1,565
EBITDA Margin	--	-54.2%	-148.86%	-171.16%	-10.03%	-98.18%
D&A For EBITDA	--	224	243	231	190	112
EBIT	-1,002	-1,280	-2,479	-2,718	-594	-1,677
EBIT Margin	-40.37%	-65.7%	-165.04%	-187.06%	-14.76%	-105.2%
Effective Tax Rate	0%	-1.62%	-1.72%	3.47%	-22.68%	0.17%

Shanghai Junshi Biosciences Co Ltd (SHJBF) Price

SHJBF Stock Price Chart

SHJBF Income

Follow-Up Questions